from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0658c/-

LFCtreatmentdescriptionclass of inhibitor

-0.170

Amikacinug/mL Amikacintranslation

0.089

Cap5-10ug/mL Capreomycintranslation

0.062

Rox10-50 ug/mL Roxithromycintranslation

-0.189

SM2-5 ug/mL Streptomycintranslation

0.528

Tet5-10 ug/mL Tetracyclinetranslation

1.006

Rif0.2-5ug/mL Rifampicintranscription

-0.752

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.264

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.417

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.019

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.518

Clofazimine10-13 ug/mL Clofaziminerespiration

0.137

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.061

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.043

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.743

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.190

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.190

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.357

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.574

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.074

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.234

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.485

Nigericin50 uM Nigericinrespiration

0.218

TRC10-150 ug/mL Triclosanrespiration

-0.756

TRZ10-25 ug/mL Thioridazinerespiration

0.247

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.435

menadione6-10 ug/mL Menadionerespiration

-0.326

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.199

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.201

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.923

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.074

NRP_1Non-replicating persistence stage 1dosRassociated

-0.236

Amp0.2mg/mL AmpicillincellWall

-0.186

Cephalexin20-100 ug/mL CephalexincellWall

-0.171

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.986

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.478

EMB10-20 ug/mL EthambutolcellWall

-0.151

Eta12-40 ug/mL EthionamidecellWall

-0.229

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.471

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.669

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.158

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.164

BZA0.12 mg/mL BenzamidearomaticAmides

0.290

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.844

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.096

H2O24 mM hydrogen peroxideDNAdamaging

-0.002

Levo10 ug/mL LevofloxacinDNAdamaging

0.121

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.234

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.200

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.153

UVUV-irradiationDNAdamaging

-1.686

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.435

Antimycin12.5-50 ug/mL Antimycin A?

-0.423

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.153

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.342

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.467

PA8240.2-2 ug/mL PA-824?

0.687

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.406

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.302

Verapamil50 uM Verapamil?

0.564

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.070

methoxatin10-20 ug/mL Methoxatin?